Retinitis Pigmentosa Market is expected to hit USD 20.47 Bn by 2029 at a CAGR of 7.8 percent – says Maximize Market Research
May 19, 2023 07:43 ET
|
MAXIMIZE MARKET RESEARCH PRIVATE LIMITED
Pune, May 19, 2023 (GLOBE NEWSWIRE) -- A global Healthcare research and business consulting firm, Maximize Market Research, has published a market intelligence report on the “Retinitis Pigmentosa...
Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates
May 11, 2023 08:00 ET
|
Prime Medicine, Inc.
-- New data further demonstrating ability of Prime Editing to correct causative mutation of CGD and highlighting potential of PASSIGE platform to multiplex edit CAR-T cells to be presented at ASGCT...
EQUITY ALERT: ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Edgio, Inc. f/k/a Limelight Networks, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EGIO, LLNW
April 27, 2023 12:23 ET
|
The Rosen Law Firm PA
NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Edgio,...
Global Gene Therapy Market Report 2023: Major Players Include Novartis, Bluebird Bio, Spark Therapeutics, Audentes Therapeutics and Voyager Therapeutics
April 06, 2023 05:13 ET
|
Research and Markets
Dublin, April 06, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and...
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT
April 04, 2023 17:15 ET
|
The Rosen Law Firm PA
NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Phathom...
Diagnostic Enzymes Market Benefits from a Continual Increase in Chronic Disease Prevalence | Fairfield Market Research Indicates a Push from Personalized Medicine
March 08, 2023 13:37 ET
|
Fairfield Consultancy Services OPC Pvt Ltd
London, March 08, 2023 (GLOBE NEWSWIRE) -- In recent years, there has been an observable increase in the prevalence of chronic diseases such as cardiovascular diseases, cancer, and diabetes, among...
Vaccines Market to Notice Utmost Growth of USD 152.39 Billion with Healthy CAGR of 10.7% by 2030, Size, Share, Trends, Drivers, Recent Trends and Growth Outlook
February 22, 2023 11:30 ET
|
Data Bridge Market Research
NEW YORK, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Vaccines Market study by “Data Bridge Market Research” provides details about the market dynamics affecting the vaccine market, Market scope, Market...
Gene Therapy Global Market Report 2023
February 13, 2023 14:31 ET
|
ReportLinker
New York, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Gene Therapy Global Market Report 2023" - https://www.reportlinker.com/p06241893/?utm_source=GNW ,...
Regenerative Medicine Market Growth Report ($37.48 Billion) Lead by Increasing Adoption of Gene Therapies | The Insight Partners
February 09, 2023 09:08 ET
|
The Insight Partners
New York, Feb. 09, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Regenerative Medicine Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global...
Gene Therapy Market Report (2022 to 2030) - Novartis AG, Spark Therapeutics Inc. (Roche), Gilead Sciences Inc., Biogen Inc., Avita Medical, Jazz Pharmaceuticals Plc. and Celgene Corporation
January 25, 2023 01:35 ET
|
Growth Plus Reports
20 Maxwell House, Singapore, Jan. 25, 2023 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global gene therapy market is expected to clock US$ 4.64 billion...